Bringing together technology with biology to improve health care
24 July 2018
There’s no doubt that the rate of change in the life sciences and health care sector is progressing at a rate of knots but is the industry moving along the technology in line with the biology?
The inherent challenge of a slow adoption rate for new technology with many health care and life science organisations can find them still working on systems that are 20 or 30 years old. (2018 Global life sciences outlook, Deloitte 2018) With patient centricity and improved patient outcomes the big measures of ROI it’s more critical than ever that the massive amount of data that is being collected is managed and analysed to allow for data driven decision making and therefore speedier and enhanced patient treatment regimens.
Where then to start with the education and culture shift? Do leaders and board members of life science and health care trusts fully understand the positive impact that advanced technology can have if they haven’t experienced it yet? Maybe the way forward is to encourage more collaboration and strategic partnership between the public and private sectors. A utopia where all stakeholders will work collaboratively whilst jointly managing risk and freely sharing knowledge during the ‘experimental’ stage. The external expertise is out there and ready to be exploited.
Here at Datatrial we have been developing software solutions for the life science and health care sector for two decades. Our new product Nucleus, a cloud based solution, was driven by our desire to enable end to end access to clinical data via a single compliant platform. Scalability, instant messaging between project teams and collaboration on documents and projects in the compliant environment will go some way to aid in speeding up the decision making process.
It’s time now to combine machine intelligence with the human insight that we have always relied on and to make that culture shift.
Next time we will focus on the role of the patient in driving change and speeding up the process. How we offer the opportunity to make the move from passive recipient of treatment ‘Thank you Doctor!’ to a valued voice in the development of new therapies.